Myeloid/lymphoid neoplasms with FGFR1 rearrangement and pemigatinib

Alessandro M Vannucchi1, Jay L Patel2, Jean-Jacques Kiladjian3

  • 1Department of Experimental and Clinical Medicine, University of Florence, Centro di Ricerca e Innovazione Malattie Mieloproliferative, AOU Careggi, Florence, Italy.

Blood
|March 4, 2026
PubMed